White House Says Congress Was Briefed About Chinese Balloon Surveillance Program In August

– Reuters

byHappy Mohamed

February 6, 2023

1 minute read

– Reuters

FDA
News

Bicycle Therapeutics To Present Trials In Progress Poster Featuring BT7480 Phase I/II Clinical Trial At The 2022 ASCO Annual Meeting

By Benzinga Newsdesk

May 26, 5:02 PM

Bicycle Therapeutics to Present Trials in Progress Poster Featuring BT7480 Phase I/II Clinical Trial at the 2022 ASCO Annual Meeting Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and

BCYC

Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $28

By Benzinga Newsdesk

November 15, 5:54 AM

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $26 to $28.

COLL

Alcoa Q3 EPS $(0.33) Misses $0.13

By Benzinga Newsdesk

October 19, 4:18 PM

Alcoa (NYSE:AA) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $0.13 by 353.85 percent. This is a 116.1 percent decrease over earnings of $2.05 per share from the same

Legal
News

Nymox Pharma Shares Relatively Quiet Following US Patent & Trademark Office Abstract For Co.’s ‘Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS’

By Benzinga Newsdesk

April 12, 11:25 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6597&f=G&l=50&d=PTXT&p=132&S1=20220412&OS=20220412&RS=20220412

NYMX

White House Says Congress Was Briefed About Chinese Balloon Surveillance Program In August

Related Posts

Bicycle Therapeutics To Present Trials In Progress Poster Featuring BT7480 Phase I/II Clinical Trial At The 2022 ASCO Annual Meeting

Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $28

Alcoa Q3 EPS $(0.33) Misses $0.13

Nymox Pharma Shares Relatively Quiet Following US Patent & Trademark Office Abstract For Co.’s ‘Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS’